Salix Pharmaceuticals Ltd: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-24

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Salix's main focus is to develop and market prescription drugs used in the treatment of various gastrointestinal diseases. Specifically, the company adopts in-licensing by entering into license and marketing agreements to acquire, develop and commercialize prescription drugs used in the treatment of gastrointestinal diseases.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Salix is a specialty pharmaceutical company engaged in the development, sale and marketing of prescription pharmaceuticals. The company has a portfolio of in-licensed products that includes: Anusol, Azasan, Colazal, MoviPrep, OsmoPrep, Pepcid, Proctocort, Visicol and Xifaxan.

    Salix derives its revenues from product sales which mainly comprise of sales of its in-licensed products. The company's total revenues increased at a CAGR of 58.0% during 2002-2006, from $33 million to $209 million.

    The company's biggest contributor to sales growth out to 2010 will be the sales of Colazal, used in pediatric patients between 5 to 17 years of age with ulcerative colitis Revenues from Colazal sales is expected to increase at a CAGR of 16%, from $104 million in 2006 to $185 million in 2010.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: salix pharmaceuticals xifaxan uk salixpharmaceuticalsuk mn pharmaceutical swot company contact

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.